Brief: Ember Lifesciences Announces New Strategic Investments Boosting Series A To $27 Million
27/05/2026 14:15
BRIEF-Ember Lifesciences Announces New Strategic Investments Boosting Series A To $27 Million May 27 (Reuters) - Ember LifeSciences:
ANNOUNCES NEW STRATEGIC INVESTMENTS BOOSTING SERIES A TO $27M
FINANCIAL TERMS OF NEW INVESTMENTS WERE NOT DISCLOSED
Source text: ID:nPn6cZXqXa
Further company coverage: AMGN.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Amgen
See all newsFactbox: Global drugmakers invest billions to boost US presence
China's Harbour BioMed to focus on another patent case after $20 million damages award
Amgen owes $20.2 million in antibody patent lawsuit, US jury says (updated)
Amgen owes $20.2 mln in antibody patent lawsuit, US jury says
Amgen taps research firm to reassess Tavneos data (updated)